Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHavelock Europa Regulatory News (HVE)

  • There is currently no data for HVE

Holding(s) in Company

8 Apr 2010 14:43

RNS Number : 9058J
Havelock Europa PLC
08 April 2010
 



 

 

 

TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARES

 

1. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attached:

Havelock Europa Plc

 

2 Reason for the notification (please tick the appropriate box or boxes):

 

An acquisition or disposal of voting rights

Yes

 

An acquisition or disposal of qualifying financial instruments which may result in the acquisition of shares already issued to which voting rights are attached

No

 

An acquisition or disposal of instruments with similar economic effect to qualifying financial instruments

No

 

An event changing the breakdown of voting rights

No

 

Other (please specify):

No

 

3. Full name of person(s) subject to the notification obligation:

 

Gartmore Investment Limited

4. Full name of shareholder(s) (if different from 3.):

 

See attached schedule

5. Date of the transaction and date on which the threshold is crossed or reached:

 

1st April 2010

6. Date on which issuer notified:

 

8th April 2010

7. Threshold(s) that is/are crossed or reached:

 

5%

 

8. Notified details:

A: Voting rights attached to shares

 

Class/type of shares

if possible using the ISIN CODE

Situation previous to the triggering transaction

Resulting situation after the triggering transaction

Number of Shares

Number of Voting Rights

Number of shares

Number of voting rights

% of voting rights

Direct

Direct

Indirect

Direct

Indirect

GB0004149356

2,298,961

2,298,961

1,250,000

1,250,000

3.244%

 

B: Qualifying Financial Instruments

Resulting situation after the triggering transaction

 

Type of financial instrument

Expiration date

Exercise/ Conversion Period

Number of voting rights that may be acquired if the instrument is exercised/ converted.

 

% of voting rights

 

C: Financial Instruments with similar economic effect to Qualifying Financial Instruments

Resulting situation after the triggering transaction

 

Type of financial instrument

Exercise price

Expiration date

Exercise/ Conversion period

Number of voting rights instrument refers to

% of voting rights

 

Nominal

Delta

 

 

Total (A+B+C)

 

Number of voting rights

Percentage of voting rights

1,250,000

3.244%

 

9. Chain of controlled undertakings through which the voting rights and/or the financial instruments are effectively held, if applicable:

 

 

 

Proxy Voting:

 

10. Name of the proxy holder:

 

11. Number of voting rights proxy holder will cease to hold:

 

12. Date on which proxy holder will cease to hold voting rights:

 

 

13. Additional information:

 

All figures are based on the Company's revised issued share capital of 38,532,050 as provided by Exshare Email contact RDU@Gartmore.com

14. Contact name:

 

RDU

15. Contact telephone number:

 

0207 782 2324

 

 

Current Holdings by Instrument Type
 
StockLine: 0414935
HAVELOCK EUROPA ORD GBP0.10
 Issued Share Capital: 38,532,050
 
Share Description
Fund Managing Co.
Shares Held
% of Issued Share Capital
UK Registered Owner
Beneficial Owner
 
 
 
 
 
Equities
 
 
 
 
HAVELOCK EUROPA ORD GBP0.10
 Gartmore Investment Limited
1,250,000
3.244%
BNY GIL GLT ACCOUNT NOMINEES LTD
GARTMORE FLEDGLING TRUST PLC
 
1,250,000
3.244%
 
 
 
1,250,000
3.244%
 
 
 
 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
HOLIPMJTMBMMBPM
Date   Source Headline
3rd Jul 201811:41 amRNSAppointment of Administrators & Nomad Resignation
29th Jun 20182:50 pmRNSResults of Annual General Meeting
29th Jun 20187:23 amRNSNotice of intention to appoint Administrators
27th Jun 20187:30 amRNSSuspension - Havelock Europa Plc
27th Jun 20187:30 amRNSFinance Update
31st May 20185:20 pmRNSAnnual Report and Accounts and notification of AGM
31st May 20183:46 pmRNS2017 Final Results
3rd May 201811:10 amRNSNotice of Results
1st May 201810:23 amRNSAppointment of Non-Executive Director
29th Mar 20184:10 pmRNSNotice of Results
6th Mar 20187:00 amRNSDirectorate Change
2nd Mar 20181:01 pmRNSFunding update
21st Feb 201812:42 pmRNSHolding(s) in Company
20th Feb 20187:00 amRNSCorporate Update
31st Oct 20178:49 amRNSStrategy Update
11th Oct 20175:57 pmRNSHolding(s) in Company
3rd Oct 20173:02 pmRNSHolding(s) in Company
27th Sep 20177:01 amRNSInterim results
27th Sep 20177:00 amRNSDirectorate Change
22nd Sep 20177:00 amRNSNotification of Major Interest in Shares
7th Sep 20177:00 amRNSTrading Statement
13th Jun 201712:51 pmRNSAGM Statement
13th Jun 201712:00 pmRNSAGM Statement
25th Apr 20177:00 amRNSFinal Results and New Financing Arrangements
10th Apr 201711:54 amRNSHolding(s) in Company
31st Mar 20177:00 amRNSAppointment of new Chief Financial Officer
20th Mar 20177:25 amRNSHolding(s) in Company
13th Mar 20173:25 pmRNSHolding(s) in Company
28th Feb 201711:12 amRNSFinal Results Pre-announcement
8th Feb 20172:57 pmRNSBlock Listing Six Monthly Return
1st Feb 20172:27 pmRNSHolding(s) in Company
25th Jan 201711:37 amRNSIssue of Equity
25th Jan 201710:56 amRNSNotification of Interests
25th Jan 201710:48 amRNSTrading Statement
20th Dec 20167:00 amRNSNew Chairman and proposed issue of new shares
22nd Sep 20167:00 amRNSHavelock Europa PLC Interim Results
14th Jul 20165:31 pmRNSBlocklisting Interim Review
14th Jun 20167:00 amRNSNotification of Interests - Andrew Burgess
10th Jun 20163:08 pmRNSResult of AGM
10th Jun 201612:00 pmRNSAGM Statement and Directorate Change
26th May 20167:00 amRNSHavelock Europa Annual Financial Report & Accounts
5th May 20167:00 amRNSDirector Shareholding
29th Apr 20167:00 amRNSHavelock Europa - Appointment of Non-Exec Director
14th Apr 20167:00 amRNSHavelock Europa Final Results
12th Feb 201610:15 amRNSHolding(s) in Company
25th Jan 20167:00 amRNSHavelock Europa PLC Trading Statement
18th Dec 20157:00 amRNSHAVELOCK EUROPA APPOINTS NOMINATED ADVISER
16th Dec 20152:57 pmRNSDirectorate Change
24th Nov 20155:39 pmRNSDirector/PDMR Shareholding
17th Nov 20158:52 amRNSReplacement: Trading Statement

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.